Vireo Growth Secures $60M Real Estate Loan at 8.5% to Own NY and FL Cultivation Facilities
VREOF is trading near its 52-week low of $8.91 (3.4% above the low) on elevated volume (2.2× avg).
Summary
Vireo Growth closed a $60M real estate loan at 8.5% fixed, refinancing $49M of existing debt and funding the $11M purchase of its Palatka, Florida cultivation facility. The loan matures in 2034 and is secured by first-priority mortgages on the New York and Florida properties.
Key Events · Financing and Capital Events · VREOF
-
$60M Term Loan Closed
On October 2, 2026, Vireo Property Holdings and four subsidiaries closed a $60M term loan with Needham Bank at a fixed 8.50% interest rate, maturing April 2, 2034.
-
Refinancing and Property Purchase
Approximately $49M refinanced the existing Seller Note held by IIP-NY 2 LLC, and $11M funded the acquisition of the Palatka, Florida cultivation facility previously leased from Rainbow Palatka FL LLC.
-
Collateral and Guarantees
The loan is secured by first-priority mortgages on the Perth, New York and Palatka, Florida properties, equity pledges from Vireo Health and holding entities, and an unsecured guarantee from Green Dragon Florida LLC.
-
Related-Party Disclosure
CEO John Mazarakis is a partner of Chicago Atlantic Group, an affiliate of the second-lien lender on the same properties; he disclosed the interest, abstained from voting, and recused himself from board approval.
Analysis · VREOF · Life Sciences
A $60 million term loan with Needham Bank closed on October 2, 2026, refinancing a $49 million seller note and funding the $11 million purchase of the Palatka, Florida cultivation facility. The 8.5% fixed rate is notably attractive for the cannabis sector, and the 10-year amortization with a 2034 maturity extends runway. The loan is secured by first-priority mortgages on both the New York and Florida properties, plus equity pledges and guarantees. A governance wrinkle: CEO John Mazarakis is a partner at Chicago Atlantic Group, an affiliate of the second-lien lender on the same properties — he recused himself from the board vote. The deal converts leased real estate into owned assets, strengthening Vireo's vertically integrated footprint in two core markets.
How filings like this one have moved
In the 30 days to Oct 8, 2026, 28.6% of the 1679 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VREOF was trading at $9.21 on OTC in the Life Sciences sector, with a market capitalization of approximately $475.3M. The 52-week trading range was $8.91 to $22.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.